Results 101 to 110 of about 2,480,847 (257)

Establishment of age-related AMH screening cutoffs in Chinese women with PCOS: a retrospective study using propensity score matching analysis

BMC Endocrine Disorders
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 5–18% of women worldwide. This disorder is characterized by two core pathological features: ovulatory dysfunction and hyperandrogenism.
Zhen Wang, Xiaojing Teng, Yanfei Liu, Yonghai Shen, Lin Ma, Yu Chen   +5 more
doaj   +1 more source

Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice

Obesity Reviews, EarlyView.
ABSTRACT Introduction Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose ...
Kate Maslin, Jill Shawe, Sinead Blowers, Michael Ceulemans, Kathryn Hart, Sam Schoenmakers, Amihai Rottenstreich, Heather Hopper, Mojca Jensterle, Angela C. Flynn, Sarah Siegelaar, Annick Bogaerts, Isy Douek, Nicola Heslehurst, Dries Ceulemans, Tricia Tan, Johnathan Pinkney, Martin Whyte, Shahrad Taheri, Roland Devlieger   +19 more
wiley   +1 more source

Expression of anti-Mullerian hormone receptor on the appendix testis in connection with urological disorders [PDF]

, 2013
The female internal sex organs develop from the paramesonephric (Mullerian) duct. In male embryos, the regression of the Mullerian duct is caused by the anti-Mullerian hormone (AMH), which plays an important role in the process of testicular descent. The
Kistamás, K, Józsa, Tamás, Dienes, B, Telek, A, Kistamás, Kornél, Telek, Andrea, Kosztka, Lívia, Kosztka, L, Csernoch, L, Kovács, Ilona, Ruzsnavszky, O, Józsa, T, Dienes, Beatrix, Ruzsnavszky, Olga, Csernoch, László, Kovács, I   +15 more
core   +1 more source

Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome

Pakistan Armed Forces Medical Journal
Objective: To determine the utility of Anti-mullerian hormone (AMH) as a diagnostic marker of Polycystic ovarian syndrome (PCOS). Study Design: Comparative cross-sectional study Place and Duration of the Study: Department of Chemical Pathology and ...
Shabana Abbas, Asma Hayat, Rabiya Shabir, Muhammad Mujahid Sharif, Asma Iqbal, Rehana Abbas   +5 more
doaj   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

[The influence of anti-Mullerian hormone on folliculogenesis].

Ginekologia polska, 2008
The main biological role of the anti-Mullerian hormone (AMH) is to induce the involution of the Muller ducts in embryos during differentiation of masculine gender. In case of women, AMH is produced in granular cells of primary, preantral and antral follicles.
Piotr, Skałba, Anna, Cygal, Anna, Dabkowska-Huć   +2 more
openaire   +1 more source

Expanded Phenotype Associated With an Intronic PPP1R12A Variant: A Case Report and Literature Review

American Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2519-2524, November 2026.
ABSTRACT Autosomal dominant PPP1R12A‐related genitourinary and/or brain malformation syndrome is a recently described multisystem disorder caused by loss‐of‐function variants in the protein phosphatase 1 regulatory subunit 12a (PPP1R12A) gene. To date, 22 affected individuals have been reported with variable brain malformations and genitourinary ...
Emily M. Bland, Amber Nakar Weinstein, Eric C. Kao, Xiaonan Zhao, Monika Weisz‐Hubshman   +4 more
wiley   +1 more source

Young bodies, aging ovaries: A systematic review and meta‐synthesis of women's perspectives on spontaneous premature ovarian insufficiency

International Journal of Gynecology &Obstetrics, Volume 175, Issue 2, Page 619-630, November 2026.
Abstract Objectives Spontaneous premature ovarian insufficiency (POI) is a condition characterized by the cessation of ovarian function before age 40, unrelated to medical interventions. It affects approximately 3.5% of women worldwide and can result in significant emotional, physical, and social consequences.
Maria Patricia Roman, Shaurya Aggarwal, Stergios K. Doumouchtsis   +2 more
wiley   +1 more source

Anti-Mullerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients

, 2013
Objective: The purpose of this study is to investigate the role of serum anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH) and antral follicle count (AFC) for the prediction of clinical pregnancy rates (CPR) in women with polycystic ovary ...
Aydogan, Begum, Oral, Engin, Sahmay, Sezai, Guralp, Onur, Cepni, Ismail, Irez, Tulay   +5 more
core   +1 more source

Determination of PCOS by Assessing Anti-Mullerian Hormone

, 2023
Introduction: Polycystic Ovarian Syndrome (PCOS) affects 20.2% of pubertal women and presents differently, making diagnosis difficult. Many employ the Rotterdam criteria, which emphasise PCO morphology, hyperandrogenism, and oligo or amenorrhea. PCOS diagnosis by AMH, which measures ovarian follicle count, is promising. GnRH neurons are affected by AMH,
openaire   +1 more source